Filipinos more willing to take COVID-19 vaccine than Dengvaxia — SWS

Filipinos more willing to take COVID-19 vaccine than Dengvaxia â SWS
This handout picture taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease, developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Handout / Russian Direct Investment Fund / AFP

MANILA, Philippines — More than half of Filipinos are willing to be inoculated against coronavirus once a vaccine becomes available, a national pollster said Thursday night. 

These findings come amid fears that the memory of a botched dengue vaccination program from three years ago will further complicate the national effort to vaccinate Filipinos against a deadly and lingering pandemic. 

According to the Social Weather Stations, 66% of adult Filipinos in September said they were willing to be take a coronavirus vaccine — in stark contrast to 62% of respondents in a survey from last year who said that Dengvaxia should not even be sold in the Philippines. 

In its September 2019 survey, SWS asked the 37% of respondents who either said Dengvaxia should be sold or were undecided on the issue if they would be willing to take the vaccine and only 42% of them said that they were. 

"This shows that Filipinos are more willing to get the COVID-19 vaccine than they were to get Dengvaxia," the pollster said. 

The remaining 31% of respondents, however, showed an unwillingness to be inoculated, with 14% saying "probably not" and 17% saying "definitely not" to the question of whether they would take a coronavirus vaccine. 

Other findings

Willingness to be be inoculated against coronavirus is highest in Mindanao at 73%, SWS found, trailed by the Visayas at 69%, then Metro Manila at 64%, and Balance Luzon at 61%. 

Men were also found by the survey to have a higher willingness to take a COVID-19 vaccine at 71% compared to women among whom willingness to be vaccinated was at 60%.  

By age group, those 25-34-year-olds posted the highest willingness to be inoculated at 70%. 

By educational attainment, willingness to be vaccinated against COVID-19 hardly varied, ranging from 59 to 67%. 

The poll, SWS said, was conducted from September 17 to 20 this year using mobile phones and computer-assisted telephone interviewing. There were 1,249 adult Filipino respondents nationwide.

— Bella Perez-Rubio

As It Happens
LATEST UPDATE: January 13, 2022 - 8:32am

Pharma giants Sanofi and GSK said on July 29, 2020, that they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine. The agreement covers a vaccine candidate developed by France's Sanofi in partnership with the UK's GSK and is subject to a "final contract."

This thread collects some of the major developments in the search for a vaccine to ease the new coronavirus pandemic. (Main photo by AFP/Joel Saget)

January 13, 2022 - 8:32am

Around a hundred Rwandans have crossed into DR Congo in recent days, saying they are fleeing the country's Covid-19 vaccination rules, local sources said on Wednesday.

Small groups of Rwandans, travelling by canoe, have landed on the southern edge of Idjwi island in Lake Kivu which straddles the border, Karongo Kalaja, the administrator of Idjwi, told AFP.

"We have already recorded at least 100" arrivals, Kalaja said. — AFP

January 3, 2022 - 6:35pm

India extends Covid vaccinations to teens aged 15-18 on Monday, after officials tightened restrictions in big cities to avoid a repeat of last year's devastating outbreak.

More than 200,000 people around India died in a huge spring virus wave that overwhelmed hospitals and crematoriums.

Health workers have since administered more than 1.4 billion vaccine doses but less than half of India's population is fully inoculated, according to government data. — AFP

December 31, 2021 - 12:14pm

A preliminary South African government study published Thursday showed a booster of the Johnson & Johnson COVIDvaccine was 85% effective in preventing hospitalization from the Omicron variant, a finding that helps revive the shot's reputation.

The South African Medical Research Council compared 69,000 health care workers who received two doses of the vaccine, based on viral vector technology, against a group of people who were unvaccinated. 

The research, which has not yet been peer reviewed, was conducted from November 15 to December 20, a time when the heavily-mutated Omicron variant increased from 82 to 98% of COVID-19 cases in the country.

When a booster shot was given six to nine months after the first dose, vaccine efficacy against hospitalization increased over time, from 63% at 0-13 days to 85% one to two months post-boost.

"This data is important given the increased reliance on the Ad26.COV.2 vaccine in Africa," wrote the authors, using the formal name for the J&J shot.

The result was also hailed by the company. In a statement, J&J scientist Mathai Mammen said it showed the vaccine "remains strong and stable over time, including against circulating variants such as Omicron and Delta." — AFP

December 25, 2021 - 3:02pm

Chile will offer its citizens a fourth coronavirus vaccine dose from February, starting with high-risk categories, President Sebastian Pinera announces.

"The main concern and priority is to protect the lives and health of our compatriots," he says at an event to mark a year since Chile launched its COVID-19 vaccination campaign.

First to get the booster shot will be health workers, old people and those with chronic diseases. — AFP

December 23, 2021 - 4:01pm

AstraZeneca says third jab 'significantly' boosts antibodies against Omicron.

  • Latest
  • Trending
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

or sign in with